Carlos del Castillo Rodríguez
Carlos del Castillo Rodríguez publishes mostly in Public Health, Environmental and Occupational Health, Sociology and Political Science and Economics and Econometrics, on topics such as Ethics and bioethics in healthcare, Public Health in Brazil and Pharmaceutical Economics and Policy.
- World rank
- #6,472,419 of 7,710,434 ranked researchers
- Rank in Spain
- #159,136 of 204,306
- Works
- 27
- Citations
- 13
- Citations per work
- 0.5
What does Carlos del Castillo Rodríguez research?
Carlos del Castillo Rodríguez's work is mostly in Medicine (34%), Social Sciences (14%), Economics, Econometrics and Finance (12%).
Their six largest subfields, inside their fields and domains; the grey slice is everything else they publish. The interactive view splits every one of their works down to single topics.
The fields and subfields, with their numbers
- Health Sciences934.3%
- Medicine934.3%
- Everything else934.2%
- Social Sciences726.0%
- Life Sciences15.5%
- 1Public Health, Environmental and Occupational Health23% of their works
- 2Sociology and Political Science14% of their works
- 3Economics and Econometrics12% of their works
- 4Pediatrics, Perinatology and Child Health6% of their works
- 5Geriatrics and Gerontology6% of their works
- 6Immunology6% of their works
Research topics
- Ethics and bioethics in healthcare
- Public Health in Brazil
- Pharmaceutical Economics and Policy
- Biosimilars and Bioanalytical Methods
- Pharmaceutical Practices and Patient Outcomes
- Pharmaceutical studies and practices
- Health Systems, Economic Evaluations, Quality of Life
- Pharmaceutical industry and healthcare
Which keywords describe Carlos del Castillo Rodríguez's research?
The keywords of their largest research topics: Medical Ethics, Consent, Patient Autonomy, Healthcare Access, Judicialization, Pharmaceutical Industry, Clinical Trials and Drug Development Costs.
- Conflict of Interest
- Cost-effectiveness Analysis
- Pediatric Pharmacokinetics
- Inappropriate Medication Use
- Biosimilars
- Drug Development Costs
- Pharmaceutical Industry
- Healthcare Access
- Consent
- Medical Ethics
- Patient Autonomy
- Judicialization
- Clinical Trials
- Generic Drugs
- Immunogenicity
- Off-Label Drug Use
- Polypharmacy
- Quality of Life
- Research Outcome
Size is their works in the topics tagged with each word, from their 8 largest topics. Each links to the topic it comes from most. The words come from the keyword list OpenAlex gives each topic, not from the text of the papers, so a word can appear that none of the papers uses.
All 19 words, with their numbers
- Medical Ethics132 topics
- Consent111 topic
- Patient Autonomy111 topic
- Healthcare Access101 topic
- Judicialization101 topic
- Pharmaceutical Industry82 topics
- Clinical Trials62 topics
- Drug Development Costs61 topic
- Generic Drugs61 topic
- Biosimilars41 topic
- Immunogenicity41 topic
- Inappropriate Medication Use41 topic
- Off-Label Drug Use41 topic
- Pediatric Pharmacokinetics41 topic
- Polypharmacy41 topic
- Cost-effectiveness Analysis31 topic
- Quality of Life31 topic
- Conflict of Interest21 topic
- Research Outcome21 topic
Where does Carlos del Castillo Rodríguez work?
Carlos del Castillo Rodríguez's main affiliation in the publication record is Universidad Complutense de Madrid, Spain.
How many publications and citations does Carlos del Castillo Rodríguez have?
OpenAlex counts 27 works and 13 citations for Carlos del Castillo Rodríguez, an h-index of 2, ranking #6,472,419 of 7,710,434 researchers worldwide on the quality score.
Ranked on field-normalised citation excellence (50%), output (30%) and citations (20%). Counts come from OpenAlex author records, which occasionally merge different people who share a name or split one person into several.
Papers, co-authors, who cited this work and researchers on the nearest topics have tabs of their own, above. Is this your page? Claim it with your ORCID iD, or request a correction or removal.
Discussion
Ask a question or share a note about Carlos del Castillo Rodríguez. Keep it to the research: no personal attacks, advertising or links. Any reader can report a post, which collapses it for everyone until it is opened.